Assessing late effects in childhood cancer survivors in Aarau, Switzerland
Official title: Young Survivors at Kantonsspital Aarau, Switzerland - A Standardized Assessment of Long-Term and Late-Onset Health Events in Survivors of Childhood and Adolescent Cancer
Run by Kantonsspital Aarau · NCT04811794 · Data updated 2026-11-12
This study looks at the long-term health effects that childhood cancer survivors experience after their treatment to help improve their follow-up care.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Kantonsspital Aarau Academic / other |
| Locations | 1 site (Aarau) |
| Status | Recruiting |
| Started | March 15, 2021 |
| Main results expected | March 15, 2071 |
| Study ends | March 15, 2072 |
| Registry record updated | August 17, 2022 |
| Trial ID | NCT04811794 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children and adolescents who have been treated for cancer at Kantonsspital Aarau and are currently in follow-up care.
✕Probably not a fit
Patients in a palliative situation or those who have not consented to the use of their medical data may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Young Survivors at Kantonsspital Aarau project focuses on evaluating the prevalence and severity of late effects experienced by survivors of childhood and adolescent cancer. This observational study collects clinical data during regular follow-up visits, starting immediately after treatment completion and continuing longitudinally. By utilizing standardized criteria for severity coding, the study aims to overcome limitations of previous retrospective studies and enhance understanding of long-term outcomes for these survivors. The findings will inform improvements in follow-up care for childhood cancer survivors.
Why it matters
Potential benefit: If successful, this study could lead to better long-term care and management strategies for childhood cancer survivors experiencing late effects.
How similar studies have gone: While many studies on late effects have been retrospective, this prospective approach aims to fill gaps in existing research, making it a novel contribution to the field.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Group A: Children and adolescents who: * have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau, * have been diagnosed at age 0-18 years, * are still in regular follow-up care at the Kantonsspital Aarau, * have finished cancer treatment and entered follow-up care, and * signed informed consent Group B: Adolescents and adults who: * fulfill the same inclusion criteria as Group A * are not in regular follow-up care anymore Exclusion Criteria: Childhood Cancer Survivors who: * are in a palliative situation or * have not given consent for further use of medical data
Where it's running
-
Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau
Aarau, Switzerland Recruiting
Study contacts
- Study coordinator: Katrin Scheinemann, MD
- Email: katrin.scheinemann@ksa.ch
- Phone: +41628384909
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community-led, family-centered communication for Hispanic childhood cancer survivors
This study tests a family-focused communication approach to help young Hispanic adult survivors, their families, and clinicians talk more effectively about survivorship care.
-
Blood biomarkers for treatment-related brain injury in children with brain tumors
This project will test whether blood plasma biomarkers can show treatment-related brain injury in children with primary brain tumors by comparing those who receive radiotherapy, those who do not, and healthy children of the same age and sex.
-
A pre-visit questionnaire and guided conversation to improve survivorship care in oncology outpatient visits
This project tests whether a short pre-visit questionnaire plus a guided conversation and tailored follow-up can help cancer survivors and their clinicians manage late effects during routine oncology outpatient visits.
-
At-home light therapy for chemo-related nerve pain in childhood cancer survivors
This study tests whether a six-week at-home light therapy program can help childhood cancer survivors who have chemotherapy-induced peripheral neuropathy.
-
Understanding the needs of siblings of children with cancer
This study looks at the emotional struggles of siblings of kids with cancer to see how they feel and what support they need during this tough time.
-
Cognitively engaging exercise to boost thinking skills in children and teens with cancer
This trial tests whether mentally challenging physical activity can improve thinking skills and self-control (executive functions) in children and adolescents undergoing cancer treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.